NIH-funded scientists identify potential malaria drug candidates

New class of compounds would target earliest stages of infection

2011-11-21

(Press-News.org) Caused by four related parasites in the genus Plasmodium, malaria is transmitted to humans via the bite of an infected mosquito. Once the bite occurs, the parasites travel to the liver, where they usually multiply rapidly for about a week without causing symptoms. Symptoms begin when the parasites spread from the liver to the rest of the body through the bloodstream. However, the parasites can lay dormant in the liver for periods ranging from several months to years before an infected person demonstrates symptoms.

Most of the malaria drugs currently in development target the symptomatic, blood stage of infection. To help achieve malaria eradication, however, a drug would ideally treat infection during both the liver and blood stages. Currently, the World Health Organization recommends only one treatment, primaquine, for the initial, liver stage of certain types of malaria infection; however, primaquine and related drugs can cause a dangerous blood disorder among patients with a genetic condition that is common in malaria-endemic regions of the world. Additionally, drug resistance has been reported, which amplifies the need to find new treatment alternatives.

By screening more than 4,000 chemical compounds that had previously shown activity against blood-stage Plasmodium, the investigators searched for a compound that would also inhibit liver-stage parasites and whose protein structure would allow the modification necessary for future drug development. They found that a group of three related compounds, known collectively as the imidazolopiperazine (IP) cluster, fit these criteria. In addition, strains of Plasmodium that had acquired resistance to other malaria drugs were susceptible to the IP cluster.

Using the IP cluster as a foundation, the researchers designed a drug candidate, GNF179, that reduced levels of one Plasmodium species by 99.7 percent and extended survival by an average of 19 days when tested in malaria-infected mice. By examining infected cells, the researchers confirmed that GNF179 was active in the liver stage of infection. The researchers note that while additional studies will be needed to fully understand the drug's mechanism of action and its specific targets within the liver, this study provides a potential starting point for developing new dual-stage antimalarial drugs.

### ARTICLE: S Meister et al. Exploring Plasmodium hepatic stages to find next-generation antimalarial drugs. Science Express DOI: 10.1126/science.1211936 (2011).

WHO: Martin John Rogers, Ph.D., program officer in NIAID's Parasitology and International Programs Branch, is available to discuss this study.

CONTACT: To schedule interviews, please contact Nalini Padmanabhan, (301) 402-1663, padmanabhannm@niaid.nih.gov.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.

ELSE PRESS RELEASES FROM THIS DATE:

Soybean adoption came early by many cultures, archaeologists say

2011-11-21

EUGENE, Ore. -- Human domestication of soybeans is thought to have first occurred in central China some 3,000 years ago, but archaeologists now suggest that cultures in even earlier times and in other locations adopted the legume (Glycine max). Comparisons of 949 charred soybean samples from 22 sites in northern China, Japan and South Korea -- found in ancient households including hearths, flooring and dumping pits -- with 180 modern charred and unburned samples were detailed in the Nov. 4 edition of the online journal PLoS ONE, a publication of the Public Library ...

What bacteria don't know can hurt them

2011-11-21

Many infections, even those caused by antibiotic-sensitive bacteria, resist treatment. This paradox has vexed physicians for decades, and makes some infections impossible to cure. A key cause of this resistance is that bacteria become starved for nutrients during infection. Starved bacteria resist killing by nearly every type of antibiotic, even ones they have never been exposed to before. What produces starvation-induced antibiotic resistance, and how can it be overcome? In a paper appearing this week in Science, researchers report some surprising answers. "Bacteria ...

UofL researcher determines how Legionnaires' bacteria proliferate, cause disease

2011-11-21

LOUISVILLE, Ky. – A University of Louisville scientist has determined for the first time how the bacterium that causes Legionnaires' disease manipulates our cells to generate the amino acids it needs to grow and cause infection and inflammation in the lungs. The results are published online today (Nov. 17) in "Science." Yousef Abu Kwaik, Ph.D., the Bumgardner Endowed Professor in Molecular Pathogenesis of Microbial Infections at UofL, and his team believe their work could help lead to development of new antibiotics and vaccines. "It is possible that the process we have ...

NASA's Hubble confirms that galaxies are the ultimate recyclers

2011-11-21

New observations by NASA's Hubble Space Telescope are expanding astronomers' understanding of the ways in which galaxies continuously recycle immense volumes of hydrogen gas and heavy elements. This process allows galaxies to build successive generations of stars stretching over billions of years. This ongoing recycling keeps some galaxies from emptying their "fuel tanks" and stretches their star-forming epoch to over 10 billion years. This conclusion is based on a series of Hubble Space Telescope observations that flexed the special capabilities of its Cosmic Origins ...

Assembly stand completed for NASA's Webb Telescope flight optics

2011-11-21

GREENBELT, Md. -- The cleanroom at NASA's Goddard Space Flight Center in Greenbelt, Md. has received a giant structural steel frame that will be used to assemble the mirrors and instruments of the James Webb Space Telescope. "This milestone is important as it marks the transition to the integration and testing phase for the Webb telescope's optical telescope element," said Lee Feinberg, Optical Telescope Element Manager for the Webb telescope at Goddard. The Webb telescope is the world's next-generation space observatory and scientific successor to the Hubble Space ...

UGA researchers develop 'super' yeast that turns pine into ethanol

2011-11-21

Athens, Ga. – Researchers at the University of Georgia have developed a "super strain" of yeast that can efficiently ferment ethanol from pretreated pine -- one of the most common species of trees in Georgia and the U.S. Their research could help biofuels replace gasoline as a transportation fuel. "Companies are interested in producing ethanol from woody biomass such as pine, but it is a notoriously difficult material for fermentations," said Joy Doran-Peterson, associate professor of microbiology in the Franklin College of Arts and Sciences. "The big plus for softwoods, ...

Combo hormone therapy has increased breast cancer risk over estrogen alone

2011-11-21

The debate about using menopausal hormone therapies to relieve symptoms in post-menopausal women has been ongoing. Is the combination therapy of estrogen and progestin better or worse than just giving women estrogen alone? In women who still have a uterus (those who have not had a hysterectomy), progestin counteracts the increased risk of uterus cancer when estrogen is given alone, but at the expense of an increase in breast cancer risk compared to estrogen alone. Now a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has found that women taking the ...

Recent advance in detonation theory

2011-11-21

A detonation wave is a chemical reaction wave propagating at the velocity of a shock wave along the explosive charge. There is great demand for a detonation model that can accurately simulate the detonation process, which would provide a theoretical basis for highly efficient military destruction, the initiation of an atomic bomb, and calculations relating to the supernova SN Ia explosion. Detonation is complicated in that it involves mechanics, chemistry and thermodynamics simultaneously. The detonation product particles move multi-dimensionally, and there are transport ...

Corals can sense what's coming

2011-11-21

Australian scientists have thrown new light on the mechanism behind the mass death of corals worldwide as the Earth's climate warms. Coral bleaching, one of the most devastating events affecting coral reefs around the planet, is triggered by rising water temperatures. It occurs when the corals and their symbiotic algae become heat-stressed, and the algae which feed the corals either die or are expelled by the coral. There have been seven major bleaching events globally in the past 30 years, the most recent being in 2010 across the Indian Ocean and Coral Triangle. Australia's ...

Heart rate recovery predicts clinical worsening in pulmonary hypertension

2011-11-21

Heart rate recovery at one minute after a six-minute walking distance (6MWD) test is highly predictive of clinical worsening and time to clinical worsening in patients with idiopathic pulmonary arterial hypertension (IPAH), according to a new study. "Ours is the first study to show that heart rate recovery at one minute of rest (HRR1) following a 6MW test is a strong predictor of clinical worsening in IPAH patients," said Omar A. Minai, MD, staff physician in the Department of Pulmonary, Allergy, and Critical Care Medicine at the Cleveland Clinic. "Predicting long-term ...

NIH-funded scientists identify potential malaria drug candidates

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: